Donations
If you find this site
informative please donate, every
donation helps us keep up
with hosting costs.
Thanks!
Warrants
Alert
Books
THE INVESTOR'S GUIDE TO WARRANTS:
Capitalize on the Fastest Growing Sector of the
Stock Market, Second Edition (Hardcover)
by Andrew McHattie Rating: ISBN-10: 027303751X
Name : KBL Merger Corp. IV
Current / Former Name: KBL Merger Corp. IV
Address: 300 Park Avenue, 12th Floor, New York, NY 10022
Phone Number: (212) 319-5555
Investor Relations Contact: N/A
Website - N/A
Warrant Details
Warrant Symbol: KBLMW
Warrants Listed: 11,500,000
Ratio: 1-for-1
Cusip Number: 48243A 11 4
ISIN Number: US48243A1144
Parent Stock Symbol: KBLM (NASDAQ)
Underlying Stock Cusip: 48243A 10 6
Expiry Date - November 6, 2025
Exercise Price: $11.50 USD
Synopsis & Listing Information
KBL Merger Corp. IV was a blank-check company established to target businesses in the healthcare, life sciences, and wellness sectors under the leadership of Dr. Lawrence Krauss.
Listing History: The company completed its initial public offering in June 2017, and its public warrants split off to trade on the Nasdaq under the symbol KBLMW.
Business Combination: On November 6, 2020, KBL Merger Corp. IV closed its corporate merger with 180 Life Sciences Corp., a clinical-stage biotechnology company. The ticker symbol for the warrants subsequently transitioned to ATNFZ.
Current Status: The warrants hit their final five-year post-merger maturity structure and formally expired on November 6, 2025.
Current / Former Name: KBL Merger Corp. IV
Address: 300 Park Avenue, 12th Floor, New York, NY 10022
Phone Number: (212) 319-5555
Investor Relations Contact: N/A
Website - N/A
Warrant Details
Warrant Symbol: KBLMW
Warrants Listed: 11,500,000
Ratio: 1-for-1
Cusip Number: 48243A 11 4
ISIN Number: US48243A1144
Parent Stock Symbol: KBLM (NASDAQ)
Underlying Stock Cusip: 48243A 10 6
Expiry Date - November 6, 2025
Exercise Price: $11.50 USD
Synopsis & Listing Information
KBL Merger Corp. IV was a blank-check company established to target businesses in the healthcare, life sciences, and wellness sectors under the leadership of Dr. Lawrence Krauss.
Listing History: The company completed its initial public offering in June 2017, and its public warrants split off to trade on the Nasdaq under the symbol KBLMW.
Business Combination: On November 6, 2020, KBL Merger Corp. IV closed its corporate merger with 180 Life Sciences Corp., a clinical-stage biotechnology company. The ticker symbol for the warrants subsequently transitioned to ATNFZ.
Current Status: The warrants hit their final five-year post-merger maturity structure and formally expired on November 6, 2025.
American Financial News
Loading the latest American market news...
American Financial News
Loading the latest American market news...
Visitor Map
Days Left
Warrant Terms
- Expiration Date: The last day the warrants can be exercised. If warrants aren't going to be exercised then they must be sold the day before the expiry date. The longer the time to expiry the more valuable the warrants.
- Leverage: A measure of how much you can increase your exposure to a share if you bought warrants instead of making a direct investment. It is the current share price divided by the current price of the warrant.
- Intrinsic Value: The difference between the exercise price and the actual trading price of the common stock. Once the common has gone over the exercise price, the warrants are "In the Money."
- Volatility: The higher the volatility rating, the higher the price of the warrant. Historical volatility is calculated by using the standard deviation of an underlying stock price over a specific period.
- Time Value: The difference between the current warrant price and its intrinsic value. Interpreted as the consideration paid for the advantage the warrant buyer has over the direct investor.
Charts
Gold Prices
Silver Prices
Platinum Prices
Palladium Prices
Visitors